RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
Clinical trial NCT05758831 · RECRUITING
Trial details
- NCT number
- NCT05758831
- Sponsor
- Rennes University Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2030-03-31
- Enrollment
- 386
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.